Plain-English translation of NCT07683065 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that examines how well secukinumab works for people who have both plaque psoriasis (a skin condition) and MASLD (a type of liver disease where fat builds up in the liver). Researchers will look at medical records from Spanish hospitals to see how many patients stay on this medication long-term and how their liver health changes over time.
Many people have both psoriasis and fatty liver disease, but we don't know much about whether this medication is safe and effective for them. This study will help doctors understand if the treatment keeps working for these patients and whether it affects their liver health.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, which means researchers will review your existing medical records from Spanish hospitals — you won't need to attend clinic visits or receive any new treatment. The study team will collect information about your prescriptions, lab results, and liver health markers from your medical records over time to see how long you stayed on the medication and how your liver responded.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
Spain